Uptake of pneumococcal vaccination in older people in northern Israel
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...
| Hlavní autoři: | , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Elsevier
2021-12-01
|
| Edice: | Preventive Medicine Reports |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2211335521002436 |